22 apr 2021
Living EuroGuiDerm - Linee guida per il trattamento sistemico della psoriasi volgare
Vaccination against SARS-CoV-2 in people with psoriatic disease - Aprile 2021
20 apr 2021
La nuova linea con celastrol nel paziente con psoriasi
Nuova dermo-cosmesi per attenuare il prurito della psoriasi
19 apr 2021
GIDV - Anno 2021 - Volume 156 - Numero 1
Febbraio 2021 - Giornale Italiano di Dermatologia e Venereologia
16 apr 2021
Dermoscopy of early melanomas
To date, is yet to be elucidated whether the body location of cutaneous melanoma can significantly affect an early dermoscopic diagnosis and, consequently, if it can be regarded as a prognostic factor.
16 apr 2021
Reassessing the Biological Significance of Congenital Melanocytic Nevi
Reassessing the Biological Significance of Congenital Melanocytic Nevi
16 apr 2021
Transient cutaneous manifestations after administration of Pfizer-BioNTech
Numerous skin manifestations associated with COVID-19
16 apr 2021
Impact of baricitinib in combination with topical steroids
Baricitinib is an oral, selective, reversible Janus kinase 1/2 inhibitor approved in the European Union and Japan and under investigation in the United States for treatment of atopic dermatitis (AD).
13 apr 2021
Clinical and Dermoscopic Factors
Infiltrative basal cell carcinoma (BCC) has a higher risk for post-surgical recurrence as compared to the most common low-aggressive superficial and nodular BCC.
13 apr 2021
Association Between Topical Calcineurin Inhibitor
Topical calcineurin inhibitors (TCIs) are commonly used as second-line treatment for atopic dermatitis.
13 apr 2021
Real-life experience with oral oxybutynin
Hyperhidrosis is a disorder of excessive sweating severely impacting on patient's quality of life (Qol).
02 apr 2021
Clinical Impact of Skin Lesions in Mastocytosis
Mastocytosis is a rare neoplasm characterized by expansion and accumulation of mast cells in various organ systems.
02 apr 2021
Clinical and dermoscopic changes of acquired
Afamelanotide (AFA) is a synthetic analogue of α-melanocyte-stimulating hormone that is approved for the treatment of patients affected by erythropoietic protoporphyria (EPP).
02 apr 2021
The effect of suture spacing on patient
The effect of suture spacing
29 mar 2021
Tralokinumab for atopic dermatitis
Tralokinumab for atopic dermatitis
29 mar 2021
Association between the dermoscopic morphology
The presence of peripheral globules is associated with enlarging melanocytic lesions
29 mar 2021
Treatment of Grover Disease With Dupilumab
Treatment of Grover Disease With Dupilumab
23 mar 2021
Is there an association between long-term antibiotics
Antimicrobial resistance (AMR) is a global health emergency.
23 mar 2021
Are biologics combined with methotrexate better
To investigate if the combination of biologics with methotrexate (MTX)
23 mar 2021
Biomarkers in atopic dermatitis
Atopic dermatitis (AD) is a common yet complex skin disease, posing a therapeutic challenge with increasingly recognized different phenotypes among variable patient populations.
16 mar 2021
Note informative per i pazienti - vaccini anti SARS-COV-2 in Italia
Vaccini anti SARS-CoV-2 in uso in Italia